Israel N, Chenciner N, Houlmann C, Streeck R E
Unité des Applications du Génie Génétique (G3), Institut Pasteur, France.
Gene. 1989 Sep 30;81(2):369-72. doi: 10.1016/0378-1119(89)90198-4.
We have constructed two new multi-purpose cloning vectors, pNI1 and pNI2, that carry the Escherichia coli gene Ecogpt encoding the enzyme xanthine-guanine phosphoribosyl transferase as a dominant selective marker. The Ecogpt gene is under the control of either the long-terminal-repeat promoter of mouse mammary tumor virus, pNI1, or the simian virus 40 early promoter, pNI2. Another feature of the vectors is a polylinker preceded by the human metallothionein IIA promoter. We have used pNI2 for the synthesis of the hepatitis B surface antigen (HBsAg) at a high level in monkey Vero cells. We show that gene amplification and a concomitant stable increase of HBsAg synthesis can be achieved in these cells using modified selective medium containing hypoxanthine, aminopterin and thymidine, i.e., increasing the aminopterin and decreasing the hypoxanthine concentrations.
我们构建了两种新型多功能克隆载体pNI1和pNI2,它们携带编码黄嘌呤 - 鸟嘌呤磷酸核糖转移酶的大肠杆菌基因Ecogpt作为显性选择标记。Ecogpt基因受小鼠乳腺肿瘤病毒的长末端重复启动子(pNI1)或猿猴病毒40早期启动子(pNI2)的控制。这些载体的另一个特点是在人金属硫蛋白IIA启动子之后有一个多克隆位点。我们已使用pNI2在猴Vero细胞中高水平合成乙型肝炎表面抗原(HBsAg)。我们表明,使用含有次黄嘌呤、氨基蝶呤和胸腺嘧啶的改良选择培养基,即在这些细胞中增加氨基蝶呤浓度并降低次黄嘌呤浓度,可以实现基因扩增以及HBsAg合成的稳定增加。